ETF Managers Group’s Avita Medical RCEL Stock Holding History

ETF Managers Group’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-35,065	Closed	-$300K	–	832
2022 Q1	$300K	Buy	35,065 +588	+2%	+$5.42K	0.01%	539
2021 Q4	$405K	Buy	34,477 +1,641	+5%	+$25K	0.01%	551
2021 Q3	$580K	Buy	32,836 +2,522	+8%	+$47.6K	0.01%	499
2021 Q2	$598K	Buy	+30,314	New	+$597K	0.01%	451

Other funds holding RCEL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

ETF Managers Group's RCEL Position: Q2 2022 in Review

ETF Managers Group sold out of Avita Medical (RCEL) in Q2 2022, closing a stake of 35,065 shares — an estimated $300K sold.

ETF Managers Group first reported a position in RCEL in Q2 2021 and held it in 4 quarters. The position peaked at $598K in Q2 2021. 56 funds tracked by Wall St. Rank hold RCEL as of Q2 2022.

ETF Managers Group reported no remaining Avita Medical position as of Q2 2022 after selling out during the quarter.
ETF Managers Group sold 35,065 Avita Medical shares in Q2 2022, an estimated $300K.
ETF Managers Group first reported a position in Avita Medical in Q2 2021 and held it in 4 quarters.
ETF Managers Group's Avita Medical position peaked at $598K in Q2 2021.
56 funds tracked by Wall St. Rank held Avita Medical as of Q2 2022.

Based on ETF Managers Group's 13F filing for Q2 2022, filed 15 Aug 2022.